The folate cycle and disease in humans

Area of Science:

• Biochemistry
• Metabolic pathways
• Nutritional science

Background:

• Hyperhomocysteinemia is prevalent in renal disease patients.
• The folate cycle plays a key role in the pathogenesis and management of kidney disease.
• Enzyme function and vitamin availability are critical for folate cycle integrity.

Purpose of the Study:

• To highlight the significance of the folate cycle in renal disease.
• To discuss the role of folate administration in treating hyperhomocysteinemia.
• To examine the impact of methylene-tetrahydrofolate reductase mutations on folate metabolism.

Main Methods:

• Review of existing literature on folate metabolism and renal disease.
• Analysis of the biochemical pathways involving folate coenzymes.
• Examination of genetic mutations affecting key folate enzymes.

Main Results:

• The 677 C-->T mutation in methylene-tetrahydrofolate reductase can aggravate hyperhomocysteinemia.
• Folate administration is an effective treatment for hyperhomocysteinemia in renal disease.
• Deficiencies in key folate enzymes can lead to severe conditions like homocystinuria.

Conclusions:

• The folate cycle is a critical factor in renal disease pathogenesis and management.
• Understanding folate enzyme properties is essential for addressing hyperhomocysteinemia.
• Targeting the folate cycle offers therapeutic potential for kidney patients.